AI and Digitization in Clinical Research and Medical Writing Series
AI and Digitization in Clinical Research and Medical Writing: A Three-Part Series
This three-part series explores the impact of AI and digitization on clinical research and medical writing, featuring insights from industry leaders. You can watch the two interviews below, and if you would like to view the webinar you can access it by filling out this short form.
1. Optimizing Clinical Trial Protocols:
In this webinar expert speakers discuss how digitized protocols are accelerating clinical research processes. The session highlights efficiency gains, strategic insights and key opportunities from protocol digitization. A case study demonstrates the benefits of integrating digitized protocols into a large language model (LLM) for document generation. Additionally, the webinar provides a forward-looking analysis of potential insights and trial optimizations for the next two to five years.
Fill out the form with watch the webinar:

Complete the form to watch the webinar.
2. Digitized Protocols in Clinical Research:
Matthew Herod from the PPD™ clinical research business of Thermo Fisher Scientific discusses how digitized protocols improve efficiency, real-world success stories, AI’s role and future prospects. The webinar further explores these topics and analyzes future trial optimizations.
3. AI in Medical Writing:
Maria Hopfgarten from Thermo Fisher Scientific’s PPD clinical research business covers the collaboration between AI and human intelligence in medical writing. She addresses benefits, opportunities, challenges and advancements in natural language processing (NLP).